Trial Profile
Treatment of SSRI-resistant depression in adolescents (TORDIA)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Citalopram (Primary) ; Fluoxetine (Primary) ; Venlafaxine (Primary) ; Paroxetine; Serotonin uptake inhibitors; Trazodone
- Indications Depression; Depressive disorders; Insomnia
- Focus Therapeutic Use
- Acronyms TORDIA
- 17 May 2010 24 week results were published in Am J Psychiatry 2010;167:782-791.
- 27 Feb 2008 Results have been published in JAMA v299 n8.
- 13 Jun 2007 Status changed from in progress to completed.